DE1104499B - Verfahren zur Herstellung neuer aminosubstituierter Triphenylaethylenverbindungen - Google Patents

Verfahren zur Herstellung neuer aminosubstituierter Triphenylaethylenverbindungen

Info

Publication number
DE1104499B
DE1104499B DEST13414A DEST013414A DE1104499B DE 1104499 B DE1104499 B DE 1104499B DE ST13414 A DEST13414 A DE ST13414A DE ST013414 A DEST013414 A DE ST013414A DE 1104499 B DE1104499 B DE 1104499B
Authority
DE
Germany
Prior art keywords
compounds
methoxyphenyl
acid
tris
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEST13414A
Other languages
German (de)
English (en)
Inventor
Bill Elpern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of DE1104499B publication Critical patent/DE1104499B/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
DEST13414A 1957-02-05 1958-02-04 Verfahren zur Herstellung neuer aminosubstituierter Triphenylaethylenverbindungen Pending DE1104499B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US638200A US3010965A (en) 1957-02-05 1957-02-05 1, 1, 2-tris-aryl-3-tertiary-amino-1-propenes, intermediates, and preparation thereof

Publications (1)

Publication Number Publication Date
DE1104499B true DE1104499B (de) 1961-04-13

Family

ID=24559045

Family Applications (1)

Application Number Title Priority Date Filing Date
DEST13414A Pending DE1104499B (de) 1957-02-05 1958-02-04 Verfahren zur Herstellung neuer aminosubstituierter Triphenylaethylenverbindungen

Country Status (7)

Country Link
US (1) US3010965A (US06197789-20010306-C00002.png)
BE (1) BE564542A (US06197789-20010306-C00002.png)
CH (1) CH377330A (US06197789-20010306-C00002.png)
DE (1) DE1104499B (US06197789-20010306-C00002.png)
FR (1) FR1209913A (US06197789-20010306-C00002.png)
GB (1) GB828762A (US06197789-20010306-C00002.png)
NL (2) NL224562A (US06197789-20010306-C00002.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1149002B (de) * 1961-10-19 1963-05-22 Giulini Gmbh Geb Verfahren zur Herstellung von blutdrucksteigernden Salzen von N, N-Dialkyl-2-aethyl-3, 3-diphenyl-propen-(2)-yl-aminen
DE1163798B (de) * 1962-01-16 1964-02-27 Giulini Ges Mit Beschraenkter Verfahren zur Herstellung blutdrucksteigernden 2-AEthyl-3,3-diaryl-propen-(2)-yl-aminen

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125572A (en) * 1964-03-17 Morpholine compounds substituted in
US3123643A (en) * 1964-03-03 Basic - substituted x a alkyl triphenyl-
DE1206426B (de) * 1960-02-29 1965-12-09 Lilly Co Eli Verfahren zur Herstellung eines Alkinamins
US3261841A (en) * 1961-05-03 1966-07-19 Sterling Drug Inc N-substituted 1,5-iminocycloalkanes and -alkenes
US3200118A (en) * 1961-10-31 1965-08-10 Geschickter Fund Med Res Spirocyclic hydrazine imides
US4028352A (en) * 1970-09-03 1977-06-07 John Wyeth & Brother Limited Benzamidopiperidine derivatives
US5491173A (en) * 1982-06-25 1996-02-13 Orion-Yhtyma Oy Tri-phenyl alkene derivatives and their preparation and use
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
CA2223595C (en) 1995-06-07 2008-08-05 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR971077A (fr) * 1947-09-05 1951-01-12 Geigy Ag J R Procédé de fabrication de diaryl-butényl-amines
FR1021301A (fr) * 1949-04-07 1953-02-17 Lundbeck Corp Amines non saturées et leur préparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB624117A (en) * 1946-12-07 1949-05-27 Wellcome Found Improvements in and relating to the preparation of substituted allylamines and propylamines
GB627139A (en) * 1947-05-28 1949-07-29 Wellcome Found Improvements in and relating to the preparation of quaternary ammonium salts of substituted propanolamines, allylamines and propylamines
US2485662A (en) * 1948-04-13 1949-10-25 Lilly Co Eli Alpha-(aminoalkyl)-stilbenes
US2515700A (en) * 1949-01-22 1950-07-18 American Cyanamid Co 3-amino-1.2 diphenyl-propanol-1
US2599497A (en) * 1949-12-05 1952-06-03 Geigy Ag J R Basic stilbene derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR971077A (fr) * 1947-09-05 1951-01-12 Geigy Ag J R Procédé de fabrication de diaryl-butényl-amines
FR1021301A (fr) * 1949-04-07 1953-02-17 Lundbeck Corp Amines non saturées et leur préparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1149002B (de) * 1961-10-19 1963-05-22 Giulini Gmbh Geb Verfahren zur Herstellung von blutdrucksteigernden Salzen von N, N-Dialkyl-2-aethyl-3, 3-diphenyl-propen-(2)-yl-aminen
DE1163798B (de) * 1962-01-16 1964-02-27 Giulini Ges Mit Beschraenkter Verfahren zur Herstellung blutdrucksteigernden 2-AEthyl-3,3-diaryl-propen-(2)-yl-aminen

Also Published As

Publication number Publication date
NL224562A (US06197789-20010306-C00002.png)
GB828762A (en) 1960-02-24
FR1209913A (fr) 1960-03-04
BE564542A (US06197789-20010306-C00002.png)
CH377330A (fr) 1964-05-15
NL110122C (US06197789-20010306-C00002.png)
US3010965A (en) 1961-11-28

Similar Documents

Publication Publication Date Title
DE1104499B (de) Verfahren zur Herstellung neuer aminosubstituierter Triphenylaethylenverbindungen
DE2257715C2 (de) N-substituierte 6-Methylen-6-desoxy-14-hydroxydihydronormorphinderivate
DD207718A5 (de) Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
EP0431371B1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
DE1518452C3 (de) 4 substituierte 2 Benzhydryl 2 butanol Derivate und Verfahren zu ihrer Herstellung
DE3438244C2 (US06197789-20010306-C00002.png)
DE1075620B (de) Verfahren zur Herstellung von Phenthiazmderivaten
DE2542791C2 (de) N,N'-Disubstituierte Naphthylacetamidine
CH645896A5 (de) Ergolinderivate.
DE2029510B2 (de) Dibenzofuranderivate und deren pharmazeutisch verträgliche Säureadditionssalze sowie Verfahren zu deren Herstellung und Arzneimittel mit einem Gehalt dieser Verbindungen
DE1095836B (de) Verfahren zur Herstellung von in 10-Stellung basisch substituierten Phenthiazinderivaten
DE2526405C2 (de) β-Piperidinoäthylraubasinat und Verfahren zu dessen Herstellung
DE1670143C3 (US06197789-20010306-C00002.png)
DE1934966A1 (de) Neue 2-Methyl-3-benzyl-3H(4,5-b)-imidazopyridine und Verfahren zu ihrer Herstellung
DE2254478A1 (de) Salicylsaeureamide
DE2003744A1 (de) In 3- und 4-Stellung disubstituierte 3-Amino-2-bicyclo[2,2,2]zu-octan-2-ole und Verfahren zu deren Herstellung
DE1470369C (de) 2 Alkyl 4 alkylamino 6 alkoxy s triazine, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
EP0000727A1 (de) 3-(4-(1,3-Diazacycloalken-2-yl)-phenyl)-1,2-benzisothiazole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel.
EP0111205B1 (de) Acridanon-Derivate
DE1595875C (de) Phenothiazine und Verfahren zu deren Herstellung
CH615181A5 (en) Process for the preparation of novel ergolene derivatives
DE2338350A1 (de) Beta-(3,4-dialkanoyloxyphenyl)-lalanin-ester
AT226723B (de) Verfahren zur Umwandlung von Thiaxanthenen
DE3243820C2 (de) N-Isopropylnoratropin-N-oxid, Verfahren für seine Herstellung und pharmazeutische Zubereitungen, die es enthalten
DE2063173C3 (de) 3- (5- Bromph enyl-2-tetr az olyl) propionylamide, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel